Findings

What do systematic reviews say?

24 questions · 24 findings · 3 reviews

No studies found 7 · 29.2%GRADE not reported 0 · 0%Very low 6 · 25%Low 8 · 33.3%Moderate 0 · 0%High 3 · 12.5%

Adverse effects ‐ any serious, specific adverse effects · people with long‐term aggression in psychosis

The review found no eligible studies for this question.

1 finding from 1 review

Haloperidol for long‐term aggression in psychosis 2016 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Global outcomes ‐ overall improvement · people with long‐term aggression in psychosis

HALOPERIDOL leads to lower global outcomes ‐ overall improvement compared with OTHER ANTIPSYCHOTICS (high certainty).

1 finding from 1 review

Haloperidol for long‐term aggression in psychosis 2016 · Cochrane Headline outcomes only
no estimate extracted
83 participants
High

Leaving the study early · people with long‐term aggression in psychosis

HALOPERIDOL showed no clear difference in leaving the study early compared with OTHER ANTIPSYCHOTICS (low certainty).

1 finding from 1 review

Haloperidol for long‐term aggression in psychosis 2016 · Cochrane Headline outcomes only
RR 1.37 [0.84, 2.24]
1 study · 110 participants
Low

Economic outcomes · people with long‐term aggression in psychosis

The review found no eligible studies for this question.

1 finding from 1 review

Haloperidol for long‐term aggression in psychosis 2016 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found